Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (5)
  • 2025 (36)
  • 2024 (42)
  • 2023 (73)
  • 2022 (54)
  • 2021 (32)
  • 2020 (8)
  • 2019 (2)

Subject

  • Drug Trafficking (4103)
  • Synthetic drugs (1097)
  • Guns/Weapons (1009)
  • OCDETF/Task Force (817)
  • Fake Pills (669)
  • Arrests/Convictions - Major (623)
  • Guilty Plea (540)
  • Seizures (Drugs/Property) (473)
  • Prescription Drugs (370)
  • Overdose (324)
  • Major Law Enforcement Operation (274)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (235)
  • Pharmaceuticals/Pharmacists/Physicians (226)
  • Money Laundering (207)
  • Gangs (199)
  • Outreach/Drug Prevention (185)
  • Fentanyl Awareness (158)
  • One Pill Can Kill (113)
  • HIDTA (104)
  • Press Conferences (68)
  • Narcoterrorism (54)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (51)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Counterfeit Pills (25)
  • Fentanyl Free America (24)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Other (11)
  • Campaigns (10)
  • Intergovernmental Affairs (9)
  • Critical Incident (7)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • Recruitment/Office of Training/Graduations (2)
  • Diversion Division (250)
  • El Paso Intelligence Center (2)

Drug Name

  • Opioids (43)
  • Oxycodone (38)
  • Fentanyl (32)
  • Hydromorphone (15)
  • Synthetic Opioids (10)
  • Benzodiazepines (8)
  • Morphine (7)
  • Methamphetamine (6)
  • Heroin (4)
  • Amphetamines (3)
  • Cocaine (3)
  • Methadone (3)
  • Steroids (3)
  • Marijuana (Cannabis) (2)
  • Ketamine (1)
  • Marijuana Concentrates (1)

Field Division

  • New England (34)
  • Washington, DC (34)
  • New York (24)
  • Seattle (24)
  • Chicago (18)
  • Houston (16)
  • New Jersey (14)
  • Atlanta (13)
  • Miami (10)
  • Sede (9)
  • El Paso (8)
  • New Orleans (8)
  • San Francisco (7)
  • St. Louis (7)
  • Dallas (5)
  • Rocky Mountain (5)
  • Phoenix (4)
  • Los Angeles (3)
  • Omaha (3)
  • San Diego (3)
  • Louisville (2)
  • Detroit (1)
Clear All Results
252 Results - Showing 181 to 190
PRESS RELEASE

Newport News Pharmacy Agrees to Pay Civil Penalty under the Controlled Substances Act

NORFOLK, Va. – Hidenwood Pharmacy, Inc., located in Newport News, and its owner, Anne Hutchens, of Seaport, have agreed to pay $125,000 to settle civil penalty claims stemming from alleged record-keeping violations associated with controlled substances. The government alleged that the Hidenwood Pharmacy failed to comply with various recordkeeping requirements...
PRESS RELEASE

Medical Director of Baltimore County Pain Management Clinic Pleads Guilty to Conspiracy to Distribute and Dispense Oxycodone

Baltimore, Maryland – Norman Rosen, age 84, of Towson, Maryland, pleaded guilty today to conspiracy to distribute and dispense oxycodone in connection with his operation of Rosen-Hoffberg Rehabilitation and Pain Management Associates, P.A., where he was Medical Director and part-owner. The guilty plea was announced by Jarod Forget, Special Agent...
PRESS RELEASE

West Barnstable Woman Sentenced for Stealing Opioids from Veterinary Office

BOSTON – A West Barnstable woman was sentenced on June 15, 2022 in federal court in Boston in connection with stealing hydrocodone, an opioid and Schedule II controlled substance, from the veterinary office where she worked. Melissa Paradise, 43, was sentenced by U.S. District Court Judge Richard G. Stearns to...
PRESS RELEASE

Sovah Health to Pay United States $4.36 Million to Settle Claims of Controlled Substance Act Violations

ABINGDON, Va. – Sovah Health has agreed to pay the United States $4.36 million to settle claims that the hospital system violated the Controlled Substances Act (CSA) on numerous occasions between 2017 and 2020. As part of the resolution, Sovah Health further agreed to be subject to a period of...
PRESS RELEASE

Newton Physician Resolves Allegations Of Improper Prescribing Practices Concerning Controlled Substances

BOSTON – Dr. Hooshang Poor, a Newton geriatric medicine physician, has agreed to pay $100,000 to resolve allegations that he prescribed controlled substances outside the usual course of professional practice, a violation of the Controlled Substances Act. Dr. Poor previously resolved allegations in February 2019 that he violated the False...
PRESS RELEASE

Former Doctor Sentenced To 46 Months In Prison For Illegally Prescribing Controlled Substances

TRUMBULL, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, announced that DAVID CIANCIMINO, 63, of Trumbull, was sentenced today by U.S. District Judge Omar A. Williams in Hartford to 46 months of imprisonment, followed by three years of supervised release, for illegally distributing prescription medication...
PRESS RELEASE

South Carolina Man Pleads Guilty to Distributing Illegal Steroids

ABINGDON, Va. – The owner of a supplement company, that manufactured and shipped unapproved drugs and illegal steroids for use by members of the bodybuilding community, pled guilty this week to a pair of federal drug charges. John Franklin Cochcroft, 37, of Lexington, South Carolina, waived his right to be...
PRESS RELEASE

Former Mercer County Pharmacist Charged with Illegally Distributing Oxycodone and Other Opiates from Trenton Pharmacy

TRENTON, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a former pharmacist was arrested today for her role in distributing and dispensing outside the course of professional practice...
PRESS RELEASE

Mercer County Accounting Professor Charged with Tax Evasion and Filing False Tax Returns

TRENTON, N.J. – A Mercer County, New Jersey, man was arrested today for tax evasion and filing false tax returns, U.S. Attorney Philip R. Sellinger announced. Gordian A. Ndubizu, 67, of Princeton Junction, New Jersey, is charged in an eight-count indictment unsealed today with four counts of tax evasion and...
PRESS RELEASE

Thermo Fisher Scientific Chemicals Acknowledges Recordkeeping Violations Of The Controlled Substances Act

BOSTON – Thermo Fisher Scientific Chemicals, Inc., an affiliate of the Waltham-based Thermo Fisher Scientific, Inc. (Thermo Fisher), has agreed to pay $25,000 to resolve allegations that it violated the Controlled Substances Act, by improperly purchasing and distributing chemicals regulated by the Act. Thermo Fisher self-disclosed these violations to the...

Paginación

  • Primera página «
  • Anterior
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Current page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster